VACCINE AGAINST NEWCASTLE DISEASE Russian patent published in 2009 - IPC A61K39/17 A61P31/12 

FIELD: medicine; biotechnologies.

SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains α-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, α-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest.

EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel.

4 tbl, 5 ex